FIELD: medicine.
SUBSTANCE: for treatment of traumatological and neurosurgical diseases ceruloplasmin is included in treatment scheme. Single daily introduced dose is 6-8 mg/kg, depending on child's age, per 200 ml of 0.9% of sodium chloride solution. Medication is introduced by intravenous drip at rate 20-25 drops a minute for not less than 12 days.
EFFECT: efficient treatment of secondary immunodeficiency with minimal side effects of ceruloplasmin treatment.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTING AND(OR) TREATING ANEMIA IN CHILDREN (VARIANTS) | 2003 |
|
RU2268745C2 |
METHOD OF TREATING PATIENTS WITH COMBINED CRANIOCEREBRAL INJURY | 2010 |
|
RU2446834C2 |
METHOD FOR EVALUATION OF INTENSIVE CARE EFFECTIVENESS IN PATIENTS WITH GRAVE TRAUMATIC BRAIN INJURY | 2010 |
|
RU2441574C1 |
METHOD FOR TREATMENT OF BACTERIAL COMPLICATION OF SEVERE CLOSED CRANIOSEREBRAL INJURY | 0 |
|
SU1623660A1 |
METHOD FOR PREDICTING PYO-INFLAMMATORY COMPLICATIONS OF CRANIOCEREBRAL INJURY | 2001 |
|
RU2212666C1 |
METHOD OF TREATMENT OF PULMONARY COMPLICATIONS IN SERIOUS CRANIOCEREBRAL INJURY | 1996 |
|
RU2139725C1 |
METHOD OF TREATMENT OF PATIENTS WITH POSTTRAUMATIC IMMUNODEFICIENCY IN ACUTE PERIOD OF BRAIN TRAUMATIC DISEASE | 1999 |
|
RU2141325C1 |
METHOD FOR TREATMENT OF CEREBROVASCULAR BRAIN DISORDERS (OPTIONS) | 2017 |
|
RU2659674C1 |
METHOD OF TREATING POSTTRAUMATIC ENCEPHALOPATHY | 2009 |
|
RU2413523C2 |
APPLICATION OF BETA-HYDROXYBUTYRATE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR PREPARATION OF MEDICATION WHICH POSSESSES CYTOPROTECTIVE ACTIVITY, INCLUDING NEUROPROTECTIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, ANTI-HYPOXIC, ANTI-STRESS, ACTOPROTECTIVE AND ADAPTOGENIC ACTIVITY, MEDICATION AND METHOD OF PREVENTION, RELIEF AND TREATMENT BY MEANS OF SAID MEDICATION | 2009 |
|
RU2426535C2 |
Authors
Dates
2009-05-20—Published
2006-07-03—Filed